Trial Site Detail

 

Drug:
Imatinib
Trial:
Study of Dose Escalation Versus no Dose Escalation of Imatinib in Metastatic Gastrointestinal Stromal Tumors (GIST) Patients
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Terminated

 

University of Iowa Hospitals and Clinics

     
Iowa City , IA 52242
USA

 

Principal Investigator:
 Mohammed Milhem, MD
Contact:
 Mohammed Milhem, MD 319-356-2324 mohammed-milhem@uiowa.edu Judy Swift, RN 319-356-8699 judy-swift@uiowa.edu
Activation Status of this Site:
 Closed
Notes about this Site:
University of Iowa Hospitals and Clinics Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.